Strasbourg, 12th June 2017 :
BIOSID is an European project coordinated by the European Diabetes Study Center (for Centre européen d’étude du Diabète or CeeD) and initiated by Defymed (developer of the MailPan ® bioartificial pancreas). The BIOSID consortium, which brings together five other expert entities, has culminated in a positive outcome thanks to results which will soon be possible to put into use.
Funded by the European Commission via the 7th Framework Programme for Research and Technological Development (FP7), BIOSID has helped to overcome several technological barriers to progress for the bioartifical pancreas MailPan ®, thus speeding up its development.